Ischaemic Stroke and Sleep Apnea in Northern Part of Finland

May 23, 2016 updated by: University of Oulu

Obstructive Sleep Apnea as a Risk Factor for Ischaemic Stroke , a Prospective Study

Obstructive sleep apnoea is a risk factor for ischaemic stroke. study hypothesis: In prospective study the investigators want to know how many ischaemic stroke patients have sleep apnoea and does thrombolysis play a role in severity of osa in six months follow up.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In prospective study the investigators include all over 18 years old patients who came to emergency room for ischaemic stroke. Exclusion criteria is not able to co-operate or need for intensive care unit.The investigators shall take 100 control patients who have ischaemic stroke and no thrombolysis and 100 study patients who will have thrombolysis. The investigators do sleep registration during hospital staying within 2 days after patients have felt ill.Follow-up registration will be done after 6 months at home.

Study Type

Observational

Enrollment (Actual)

256

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • northern Finland
      • Oulu, northern Finland, Finland, 90029
        • Oulu university hospital,department of neurology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

residents of Oulu university hospital area. consecutive patient sampling

Description

Inclusion Criteria:

  • over 18 years old patients that have cerebral palsy and are able to participate to the study.

Exclusion Criteria:

  • no co-operation and need for intensive care unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Nasal CPAP
We want to study the nasal-cpap treatment and it's compliance in sleep apnea patients with ischaemic stroke.
Nasal CPAP treatment for obstructive sleep apnoea
no Nasal CPAP
No nasal-cpap in sleep apnea patients with ischaemic stroke.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cerebral palsy events and severity of osa
Time Frame: from six months to twenty four months
in prospective study outcome measure is severity of osa in 6months follow-up
from six months to twenty four months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tarja Saaresranta, Md PhD, University hospital of Turku

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

May 21, 2013

First Submitted That Met QC Criteria

May 22, 2013

First Posted (Estimate)

May 23, 2013

Study Record Updates

Last Update Posted (Estimate)

May 24, 2016

Last Update Submitted That Met QC Criteria

May 23, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Write a paper.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Nasal CPAP

3
Subscribe